The Journal of Urology
Volume 180, Issue 2 , Pages 435-436 , August 2008

The Undoing of Ureteral Obstruction From Malignancy—Who and How?

  • J. Stuart Wolf Jr.

      Affiliations

    • Financial interest and/or other relationship with Terumo Corp and Omeros Corp.

References 

  1. Rosevear HM, Kim SP, Wenzler DL, Faerber GJ, Roberts WW, Wolf JS. Retrograde ureteral stents for extrinsic ureteral obstruction: nine years' experience at University of Michigan. Urology. 2007;70:846
  2. Borin JF, Melamud O, Clayman RV. Initial experience with full-length metal stent to relieve malignant ureteral obstruction. J Endourol. 2006;20:300
  3. Eyre RC, Benotti PN, Bothe A, Cady B, Steele G. Management of the urinary tract involved by recurrent cancer. Arch Surg. 1987;122:493
  4. Ku JH, Lee SW, Jeon HG, Kim HH, Oh SJ. Percutaneous nephrostomy versus indwelling ureteral stents in the management of extrinsic ureteral obstruction in advanced malignancies: are there differences?. Urology. 2004;64:895
  5. Desgrandchamps F, Leroux S, Ravery V, Bochereau G, Menut P, Meria P, et al. Subcutaneous pyelovesical bypass as replacement for standard percutaneous nephrostomy for palliative urinary diversion: prospective evaluation of patient's quality of life. J Endourol. 2007;21:173
  6. Schmidbauer J, Kratzik C, Klingler HC, Remzi M, Lackner J, Marberger M. Nephrovesical subcutaneous ureteric bypass: long-term results in patients with advanced metastatic disease—improvement of renal function and quality of life. Eur Urol. 2006;50:1073
  7. Trueba Arguinarena FJ, Fernandez delBusto E. Self-expanding polytetrafluoroethylene covered nitinol stents for the treatment of ureteral stenosis: preliminary report. J Urol. 2004;172:620
  8. Wakui M, Takeuchi S, Isioka J, Iwabuchi K, Morimoto S. Metallic stents for malignant and benign ureteric obstruction. BJU Int. 2000;85:227

PII: S0022-5347(08)01273-1

doi: 10.1016/j.juro.2008.05.037

The Journal of Urology
Volume 180, Issue 2 , Pages 435-436 , August 2008

Article Tools